Related Experiment Video
Updated: Mar 7, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Cutaneous and non-cutaneous diseases due to Mycoplasma pneumoniae in children
Hanna Lindemann1, Maximilian David Mauritz2, Victoria Rehmann2
1Department of Dermatology and Allergology, University Hospital Basel, Basel, Switzerland.
Abstract:
Mycoplasma pneumoniae (MP) is a common pathogen responsible for diverse infections in children and adolescents, primarily affecting the respiratory tract. Besides causing atypical pneumonia, MP can also lead to extrapulmonary manifestations, including mucocutaneous, hematological, neurological, cardiac, and gastrointestinal symptoms. These extrapulmonary manifestations are often overlooked, complicating diagnosis and management. Here, we delineate the spectrum of cutaneous and non-cutaneous diseases caused by MP in children, focusing on the pathophysiology, clinical features, and treatment of mucocutaneous manifestations.
Insights
Mycoplasma pneumoniae infections in children can cause serious skin and non-lung symptoms beyond pneumonia. This study details these extrapulmonary issues, aiding diagnosis and treatment.
Area of Science:
- Pediatrics
- Infectious Diseases
- Dermatology
Background:
- Mycoplasma pneumoniae (MP) is a frequent cause of respiratory infections in children and adolescents.
- MP infections can extend beyond the respiratory tract, leading to various extrapulmonary manifestations.
- These non-respiratory symptoms, including mucocutaneous, hematological, neurological, cardiac, and gastrointestinal issues, are often underrecognized.
Purpose of the Study:
- To describe the range of cutaneous and non-cutaneous diseases linked to Mycoplasma pneumoniae in pediatric populations.
- To focus on the pathophysiology, clinical presentation, and therapeutic strategies for MP-associated mucocutaneous manifestations.
- To enhance awareness and understanding of the diverse clinical spectrum of MP infections.
Main Methods:
- Literature review and synthesis of existing studies on Mycoplasma pneumoniae in children.
- Analysis of clinical case reports and observational studies detailing extrapulmonary manifestations.
- Focus on dermatological and related symptoms, including pathophysiology and treatment.
Main Results:
- Mycoplasma pneumoniae causes a wide array of mucocutaneous conditions in children, such as erythema multiforme, Stevens-Johnson syndrome, and urticarial rashes.
- Non-cutaneous manifestations include hematological abnormalities (anemia, thrombocytopenia), neurological complications (encephalitis, meningitis), cardiac involvement (myocarditis), and gastrointestinal disturbances.
- The pathophysiology often involves immune-mediated responses to the infection.
Conclusions:
- Mycoplasma pneumoniae infections present a broad clinical spectrum in children, extending significantly beyond respiratory symptoms.
- Recognizing and diagnosing extrapulmonary manifestations, particularly mucocutaneous conditions, is crucial for effective management.
- Further research is needed to fully elucidate the mechanisms and optimize treatment for these diverse presentations.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
